New hope for advanced cervical cancer: targeted drug combo shows promise
NCT ID NCT03786081
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This trial tested a drug called tisotumab vedotin, alone or with other medicines, in people with cervical cancer that had come back or spread. The study included 214 participants and aimed to find the best dose and see if the tumors shrank. The trial was stopped early, but the results help guide future treatments for advanced cervical cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMC Medical Research
Amsterdam, Netherlands
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
Amsterdam UMC, Locatie AMC
Amsterdam, 1105 AZ, Netherlands
-
Arizona Oncology Associates
Phoenix, Arizona, 85016, United States
-
Augusta University
Augusta, Georgia, 30912, United States
-
Azienda Ospedaliera Cannizzaro
Catania, 95100, Italy
-
Baptist MD Anderson Cancer Center
Jacksonville, Florida, 32207, United States
-
Baskent University Adana Application and Research Center
Adana, 01220, Turkey (Türkiye)
-
Baskent University Ankara Hospital
Ankara, 06490, Turkey (Türkiye)
-
Beatson West of Scotland Cancer Centre
Glasgow, Strathclyde, G12 OYN, United Kingdom
-
Billings Clinic Cancer Center
Billings, Montana, 59101, United States
-
Brown University - Women's and Infant Hospital
Providence, Rhode Island, 02905, United States
-
CHU UCL Namur
Namur, 5000, Belgium
-
Carilion Clinic
Roanoke, Virginia, 24016, United States
-
Centre Hospitalier Universitaire (CHU) de Liège
Liège, 4000, Belgium
-
Centre Hospitalier de l'Ardenne
Libramont, 6800, Belgium
-
Cleveland Clinic
Cleveland, Ohio, 44106, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
-
Cork University Hospital
Cork, Ireland
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Erasmus Medisch Centrum
Rotterdam, 3015 CC, Netherlands
-
Erasmus University Medical Center Rotterdam
Rotterdam, 3015, Netherlands
-
Fakultni nemocnice Bulovka
Prague, 180 81, Czechia
-
Fakultni nemocnice Olomouc
Olomouc, 775 20, Czechia
-
Fakultni nemocnice Olomouc
Olomouc, 77520, Czechia
-
Fakultni nemocnice Ostrava
Ostrava-Poruba, 70852, Czechia
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Grand Hôpital de Charleroi
Charleroi, 6000, Belgium
-
Grand Hôpital de Charleroi
Loverval, 6280, Belgium
-
Hospital 12 De Octubre
Madrid, 28041, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 8035, Spain
-
Hospital Universitario Reina Sofia
Córdoba, 14004, Spain
-
Hospital Universitario Virgen de la Arrixaca
El Palmar, 30120, Spain
-
Huntsman Cancer Center
Salt Lake City, Utah, 84112, United States
-
IEO Istituto Europeo di Oncologia
Milan, 20141, Italy
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
-
Istituto Nazionale Tumori Fondazione G. Pascale
Naples, 80131, Italy
-
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, 15213, United States
-
Mater Misericordiae University Hospital
Dublin, D07 R2WY, Ireland
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Montana Cancer Consortium
Billings, Montana, 59102, United States
-
Nemocnice Na Bulovce
Prague, 18081, Czechia
-
Ohio State University Wexner Medical Center
Hilliard, Ohio, 43026, United States
-
Olive View - UCLA Research and Education Institute
Sylmar, California, 91342, United States
-
Oschner Clinic
New Orleans, Louisiana, 70121, United States
-
Radboudumc
Nijmegen, 6525 GA, Netherlands
-
Rigshospitalet
Copenhagen, 5072, Denmark
-
Royal Marsden Hospital- Sutton
Sutton, Surrey, SM2 5PT, United Kingdom
-
SUNY Downstate Medical Center
Brooklyn, New York, 11203, United States
-
Sainte-Elisabeth
Namur, 5000, Belgium
-
St Francis Hospital Cancer Center
Greenville, South Carolina, 29607, United States
-
UMC Utrecht
Utrecht, 3508 GA, Netherlands
-
UZ Leuven
Leuven, 3000, Belgium
-
Univ California, Irvine Medical Center
Orange, California, 92868, United States
-
Universitair Medisch Centrum Groningen (UMCG)
Groningen, 9713 GZ, Netherlands
-
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, 2650, Belgium
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Universitaire Ziekenhuizen Leuven,
Leuven, Belgium
-
University Hospital Waterford
Waterford, Ireland
-
University Medical Center Utrecht (UMC Utrecht)
Utrecht, 3584, Netherlands
-
University of Chicago
Chicago, Illinois, 60525, United States
-
University of Cincinnati Physicians Group
Cincinnati, Ohio, 45206, United States
-
University of Kansas Medical Center
Westwood, Kansas, 66205, United States
-
University of North Carolina Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
Velindre Cancer Centre
Cardiff, South Glamorgan, CF14 2TL, United Kingdom
-
Vseobecna fakultni nemocnice v Praze
Prague, 128 51, Czechia
-
Vseobecna fakultni nemocnice v Praze
Prague, 12851, Czechia
-
Waterford Regional Hospital
Waterford, X91 ER8E, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?
- Can robotic surgery match open surgery in beating cervical cancer?
- Blood test clues could sharpen cervical cancer treatment